Floatz logo

Acellular Pertussis Vaccine

FIGO Stage III Ovarian Cancer 2014

Mayo ClinicPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

5 Active assets in the FIGO Stage III Ovarian Cancer 2014 cohort.

Asset / SponsorPhaseRating
Multi-Epitope Folate Receptor Alpha-Loaded Dendritic Cell Vaccine
Mayo Clinic
Phase 2B
ADSORBED PURIFIED PERTUSSIS VACCINE
Mayo Clinic
Phase 2CCC
Tetanus Toxoid
Mayo Clinic
Phase 2CCC
DIPHTHERIA TOXOID ADSORBED
Mayo Clinic
Phase 2CCC
DIPHTHERIA TOXOID
Mayo Clinic
Phase 2CCC
Ruxolitinib Phosphate
NRG Oncology
Phase 1/2CCC

Same molecule, other indications

Acellular Pertussis Vaccine is also rated in:

Advanced Fallopian Tube High Grade Serous AdenocarcinomaDormant
CCC
Indicative ·
53 / 100
View asset →
Advanced Fallopian Tube CarcinomaDormant
CCC
Indicative ·
53 / 100
View asset →
Advanced Ovarian CarcinomaDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →